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The Receptor Guanylyl Cyclase C: Insights into Expression and Regulation 
Cells are under constant exposure to the external envrronment and have the 
ab~lity to respond to changes through a complex process termed as ''cellular stgnal 
transduction" Control of this life sustaining actlvity IS medrated by the concerted act~ons 
of hormones and neurotransm~tters Cyclic GMP (cGMP). a ublqurtous second 
messenger, has ai..l important roie to play In cellular s~gnal transduction. Cyclrc GMP IS 
synthestzed by both soluble guanylyl cyclases and receptor guanylyl cyclases Receptor 
guanylyi cyclases have a modular domain organization, and are div~ded Into an 
extraceliuiar ligand-b~nding domaln, a s~ngle transmembrane domain, a region with 
sequence similarity to that of protein kinases, the kinase homology domarn (KHD) and a 
C-terminal guanylyl cyclase domain. The independent structural domarns in receptor 
guanylyl cyclases do not functron as completely separate entitles, but perform 
interdependent funct~ons to ensure preclse moduiat~on of the catalyt~c activity. 
Guanylyl cyclase C (GC-C) is the membrane-bound receptor for the heat-stable 
eglterotoxin (ST) peptides and for the endogenous peptide ligands guanylin, uroguanylrn, 
and iymphoguanylin. GC-C IS predominantly expressed on the aprcal surface of eprthelral 
cells of the intestine, and act~vation of GC-C by ST leads to an increase in rntracellular 
cGMP levels Cyclic GMP cross-act~vates prote~n kinase A and protein k~nase G, which 
phosphorylate and act~vate the cyst~c frbros~s transmembrane conductance regulator 
(CFTR) leading to chloride Ion secretion. Thrs in turn causes secret~on of water ~n to  the 
lumen, which results in "traveller's d~arrhoea" associated wrth the ST peptides. The 
endogenous peptides guanylin and uroguanylin have a lower afflnrty for GC-C than the 
ST peptides and are produced withln the intestinal mucosa to serve as paracrrne and 
autocrine regulators of intestinal fluid and electrolyte secretion. 
Adenine nucleotides have been shown to regulate the actlvrty of GC-C, 
presumably by bindrng to the KHD. Structural modelling studies have suggested that the 
KHD of GC-C can adopt a structure similar to that of protein kinases, and that Lys516, 
corresponding to the conserved lysine in the protein kinases, is essential for mediating 
ATP effects in GC-C. In the current study the role of the KHD in GC-C signalling has 
been investigated. Earlier studies have shown contrasting results that deletion of the 
KHD in GC-C either results in a constitutively active or an inact~ve receptor To further 
delineate the role of this domain, a deletion (491-568 amino acid residues of GC-C) 
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containing the potential ATP blndlng s~ te  (Lys.516) was generated This deletlon in the 
KHD resulted in significant lnactlvatlon of GC-C, both In terms of Iigand-stimulated 
guanylyl cyclase activlty and activity In the presence of MnGTP as substrate. 
Although the KHD has sequence similarity to the catalytic domain of protein 
klnases, it lacks the crltical hrstldine-arg~nine-aspartate (HRD) motif that has been shown 
to be essential for phosphor-transfer activity In protern kinases. Thls 1s replaced by 
histldlne-glycine-arginlne (HGR) In GC-C. Given the apparent structural homology 
between the KHD of GC-C and protein kinases, it would be interesting to examine the 
posslbillty of introducing the critlcal HRD motif In GC-C and study how that would 
modulate the activlty of GC-C. Through site-directed mutagenesis, Gly613 and Arg614 
residues In GC-C were mutated to Arg and Asp respectively. Interestingly, thls mutatlon 
also resulted in significant inactivation of GC-C. When the Invariant krnase residues are 
either mutated or introduced in the KHD, there is a loss of ligand stimulated activity, 
suggesting that any perturbation In sequence results in loss of slgnal transmission from 
the extracellular ligand blndlng domarn to the intracellular domaln. Thls could suggest 
that the KHD of GC-C has evolved to function as a regulatory domain rather than a 
typlcal kinase, and may provlde an explanation for the presence of a pseudok~nase 
domain In a number of signalling proteins. 
In typical kinases, "open" or "closed" structures are observed in the absence or 
presence of ATP respectively, and thls conformational flexibility is a central feature of the 
regulatory mechanism. Earlier studies have shown that ATP could interact with the KHD 
and modulate GC-C activity by altering the oligomeric state, which could be associated 
with a dramatic alteration In the conformation of the receptor. Interestingly, a monoclonal 
antibody, GCC:4D7, raised against the KHD of human GC-C (460 to 784 amino acld 
residues) and available In the laboratory, does not bind to GC-C in the presence of ATP. 
In addition, mutant GC-CK51BA failed to react with the GCC:4D7 monoclonal antibody. The 
loss of reactivity could be either due to inaccessibility of the epitope because of 
conformational changes brought about upon ATP binding or due to direct ATP binding to 
the epitope. Epitope analys~s by phage display revealed that 517DLKHND522 1s the 
epitope of GCC:4D7, which is present immediately C-terminal to Lys516. The loss of 
reactivity of the antibody in the presence of ATP was further found to be an inherent 
property of the paratope of GCC:4D7, slnce both the whole antibody and the derived 
ScFv failed to recognize GC-C in the presence of ATP. These flndings indirectly indicate 
that on binding of ATP to the KHD, there could be conformational changes as observed 
in typical kinases, which alter the reactiv~ty of the antibody, and these conformational 
changes in turn regulate receptor activity. 
Since the KHD has a regulatory role, compounds that interact with the KHD could 
serve as regulators of GC-C activlty. To invest~gate this, it was decided to study the 
effects of different protein kinase inhibitors that either act as ATP analogues or substrate 
rnlrnlcs, on GC-C activity. Interestingly, Tyrphostins, potent tyrosine kinase inhibitors, 
were found to inhibit GC-C activity unlike other kinase rnhibitors such as staurosporine 
and genistein. Tyrphostin A25 inhtbited the guanylyl cyclase activity of GC-C in vitro, and 
no inhibition was seen with an inactive analogue, Tyrphostin A l ,  indicating the 
requirement of a specific side chain in the Tyrphostins to bring about inhibition. lnhibit~on 
was reversible and non-competitive with respect to the substrate (MnGTP). 
The KHD could be the site for Tyrphostin binding, thereby modulatrng cyclase 
activity. To assess this, the guanylyl cyclase domain of GC-C was expressed in insect 
cells and was found to be catalyt~cally active. Tyrphostin A25 inhibited the catalytic 
activity, indicating that the cyclase domain of the receptor was the site for Tyrphost~n 
b~nding. In agreement with this. the cyclase activit~es of membrane-bound guanylyl 
cyclase A and soluble guanylyl cyclase were also inhibited. 
In order to evaluate the structural determinants of the basic Tyrphostin skeleton 
that are required for the inhrbitron of guanylyl cyclase activity, the effects of a variety of 
Tyrphostins in bringing about the inhibition of guanylyl cyclase activity were investigated. 
Interestingly besides Tyrphostin A25, related compounds such as AG18, AG82, AG213, 
AG490, AG494, AG555, AG556 and AG1288 also inhib~ted GC activity, compared to 
others (AG9, AG43, AG370 and AG879) which inhibited the activity poorly. These 
findings indicate that the hydroxyl groups present in active Tyrphostins probably act by 
forming critical hydrogen bonds at the Tyrphostin binding site in GC-C, and appear to be 
essential for inhibition. 
Tyrphostin A25 did not inhibit ST-mediated activation of GC-C when applied to 
intact cells. Interestingly, Tyrphostin AG555 inhibited ST-mediated activation of GC-C In 
intact cells, and the inhibition was reversible. Tyrphostin AG555 did not have any effect 
on soluble guanylyl cyclase activity. These results caution against the interpretation of 
cellular experiments using Tyrphostins as being solely due to inhibition of tyrosine 
kinases. Effective inhibitors of specif~c guanylyl cyclase signalling pathways could 
provide information in determlnlng the functions of cGMP and of the individual cyclase 
receptors In many cells throughout the body where the roles of thrs cyclrc nucleotlde are 
not understood. Therefore novel rnhibltors of guanylyl cyclases can be synthesized uslng 
the Tyrphostins as a backbone. 
The major site of expression of GC-C is the intestlnal eplthellal cell, although GC- 
C is also expressed in extralntestinal tissue such as the kidney, airway epithelium, 
perinatal liver, stomach, brain, and adrenal glands. The functlon of GC-C in these tissues 
is not clearly understood. So as to Investigate the existence of GC-C signalling pathway 
and its posslble role in extraintestlnal tissues, it was decided to study the presence of 
GC-C, uroguanylln, guanylin mRNA, and protein kinase G-ll In both male and female 
reproductive organs and results indrcated expression of the mRNA for all these genes in 
the reproductive tissue of the male and female rat. Based on the obse&atlon that CFTR 
plays an important role in male reproduction and the epididymis IS hlghly dependent on 
CFTR for its functlon, it is possible to suggest that the GC-C signalling pathway may also 
regulate fluid and electrolyte balance of epididymis In an endocr~nelparacrrne fashion. 
Western blot analysls uslng a monoclonal antlbody to GC-C revealed the 
presence of d~fferentially glycosylated forms of GC-C In the caput and cauda ep~dldymls. 
Exogenous additlon of uroguanylin to eprdidymal minces resulted in cGMP accumulat~on, 
suggesting an autocrine or endocrine activation of GC-C In th~s tissue. 
lmmunohistochemical analyses using the monoclonal antibody GCC:4D7 demonstrated 
expressron of GC-C in the tubular epithelial cells of both the caput and cauda epididymis. 
Functional GC-C was also expressed In the rmmature rat epididymis and was localised in 
both tubular epithelium and the smooth muscle lining of the tubule. 
In intestinal cells, the GC-C promoter is regulated by hepatocyte nuclear factor 4 
(HNF-4) and Cdx2 transcriptional factors. So as to investigate whether GC-C is regulated 
similarly in the epididymis, primary epithelial cultures from the mature rat epididymis 
were established. lmmunocytochemistry studies using a monoclonal antibody raised 
agalnst cytokeratin, an epithelial cell marker, revealed the presence of epithelial cells in 
culture. The presence of GC-C was demonstrated by RT-PCR and immunocytochemistry 
studies. The presence of HNF-4 and Cdx2 transcriptional factors in this tissue was 
validated by RT-PCR analysis followed by sequence analysis of the PCR products. 
It was of interest to investigate whether HNF-4 and Cdx2 are essential for 
transcriptional regulation of GC-C in the epldidymis. In order to address this, wild-type 
GC-C promoter-luclferase constructs along w~ th  indiv~dual mutations In the HNF-4 and 
Cdx2 srtes were trans~ently transfected Into prlmary ep~thelial cells. The promoter wh~ch 
lacked elther HNF-4 or Cdx2 binding sites was ~nactlve. Thls suggests that as In the 
intestine, transcription of GC-C In epid~dymls also requires HNF-4 and Cdx2 transcr~ption 
factors. These findings therefore suggest that the GC-C s~gnalling pathway could 
converge on CFTR in the epidldymis and perhaps control f lu~d and ion balance for 
optrmal sperm maturatron and storage In this t~ssue. 
In conciusron, the current study has attempted to understand the role of the KHD 
in GC-C signallrng and mechanism of regulatron of GC-C act~v~ty by ATP. Studies 
suggest that novel nucleotide cyclase ~nhib~tors based on the Tyrphostin scaffold can be 
developed. These could aid in a greater understanding of nucleotlde cyclase structure 
and function. The existence of the GC-C signalling pathway in reproductive tissues and 
in epididym~s in particular suggests a novel role for GC-C in controll~ng germ cell function 
and maturation. 
